NCT00091429View on ClinicalTrials.gov

Ranolazine SR in Patients With Chronic Angina Who Remain Symptomatic Despite Maximal Treatment With Amlodipine

PHASE3CompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

February 28, 2005

Study Completion Date

February 28, 2005

Conditions
Angina
Interventions
DRUG

Ranolazine

Sponsors

Lead Sponsor

Gilead Sciences
All Listed Sponsors
lead

Gilead Sciences

INDUSTRY